The first-ever neuroimmune modulation implant has been approved for people with moderate to severe rheumatoid arthritis (RA) who haven't found relief with traditional medications. It's a potentially life-changing technology that can zap pain by delivering one-minute electrical pulses to the vagus nerve – a key neural pathway that regulates inflammation. The US Food and Drug Administration (FDA) has greenlit the device developed by California's SetPoint Medical, based on positive outcomes from the RESET‑RA clinical trial – a 242-patient, randomized, double-blind, sham-controlled study. It showed measurable improvements in disease activity by three months, with sustained benefits at 12 months. Impressively, 75%...